Stay updated on Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    Revision in the page history shows the site version updated from v3.2.0 to v3.3.2, a minor update with no changes to study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-24T17:44:21.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Removed the government funding/operating status notice banner from the page; the rest of the study record remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-17T17:28:48.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The latest history entry shows a routine update to the study status and contacts; no changes to core study content or reported outcomes are observed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-11-03T09:53:36.000Z thumbnail image
  6. Check
    71 days ago
    Change Detected
    Summary
    Core status messaging updated to reflect funding-related operational details and a version bump to v3.2.0; previous v3.1.0 reference removed.
    Difference
    7%
    Check dated 2025-10-05T14:32:38.000Z thumbnail image
  7. Check
    78 days ago
    Change Detected
    Summary
    Page revision updated from v3.0.2 to v3.1.0, indicating a version bump with no other substantive content changes.
    Difference
    0.2%
    Check dated 2025-09-28T09:52:13.000Z thumbnail image
  8. Check
    93 days ago
    Change Detected
    Summary
    Revision updated from v3.0.1 to v3.0.2. The 'Back to Top' link has been removed.
    Difference
    0.4%
    Check dated 2025-09-14T00:15:28.000Z thumbnail image

Stay in the know with updates to Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab/Vibostolimab vs Durvalumab in Lung Cancer Clinical Trial page.